COLLEEN WHELEN: Open Payments
NPI 1245965508 · ANDERSON, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$582 in 26 payments from 8 companies in 2025. Trend: 2023 $116 · 2024 $612 · 2025 $582
Food & beverage: $582
| Company | Payments | Amount |
|---|---|---|
| Amgen Inc. | 9 | $200 |
| Novo Nordisk Inc | 5 | $118 |
| PFIZER INC. | 3 | $100 |
| Lilly USA, LLC | 4 | $65 |
| VERTEX PHARMACEUTICALS INCORPORATED | 2 | $32 |
| Aimmune Therapeutics, Inc. | 1 | $29 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 1 | $21 |
| GlaxoSmithKline, LLC. | 1 | $18 |
Products named: EVENITY, PREVNAR 20, MOUNJARO, Rybelsus, Ozempic, JOURNAVX, ZENPEP, XIFAXAN.
Industry payments across CA — which companies pay providers there.
